Big Win Against Evergreening For Tuberculosis Sufferers In India, But Will Johnson & Johnson Allow Those In Other Countries To Benefit?
“Evergreening” refers to the practice by pharmaceutical companies of making small changes to a drug, often about to come off patent, in order to gain a new patent that extends its manufacturer’s monopoly control over it. The first Techdirt post about evergreening appeared almost exactly ten years ago. It concerned the rejection by the Indian...big pharma·drugs